Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Bridging the Gap...
View:
Post by Eoganacht on Jul 06, 2023 1:25pm

Bridging the Gap...

It seems that over 90% of this pp is just two Theralase insiders putting up $1,110,000 of their own money in order to keep the company going until we get the joint venture agreement. If nothing else, these insiders are exhibiting a great deal of confidence in an imminent jv and in the company's bright future in general.
Comment by CAinPlap on Jul 06, 2023 3:21pm
I think the 1,110,000 is the number of shares they subscribed to, not the dollar amount.
Comment by Eoganacht on Jul 06, 2023 3:48pm
If that's right it would be $277,500 which would be 23% of the pp
Comment by horseshack on Jul 06, 2023 3:56pm
2 groups at 80,000 shares = 160,000 x25 cents =$90,000 plus insiders $1,100,000 = $1,2000,000
Comment by Eoganacht on Jul 06, 2023 3:53pm
You're right CAinPlap it's 1,110,000 shares not dollars.
Comment by Jaro1977 on Jul 06, 2023 4:06pm
There were 23 placees, x2 insiders, x2 institutions, x19 private individuals
Comment by riverrrow on Jul 06, 2023 9:30pm
It would be interesting to know if the 19 private investors participating in this most recent pp also participated in the last financing.  Is TLT being kept afloat by a small, loyal group including Roger and Kristina?
Comment by ScienceFirst on Jul 06, 2023 10:08pm
Participation of insiders cannot be seen negatively considering what they know.  At least, they put their money where their mouth is.  So that's securing for us and it sends another positive signal. Market conditions for financing are not obvious.  Once we get FDA Breakthrough designation, future pps will attract newer investors.
Comment by StevenBirch on Jul 07, 2023 8:10am
If insider selling is almost always considered a major negative then the opposite must be true of continued buying. Also they are keeping dilution to a minimum and preserving their 'control' position. It's all good.
Comment by Vikingstock on Jul 07, 2023 9:14am
Agreed, asked some questions about financings, small pps and warrants at AGM. I was left with impression that indeed a group of shareholders and insiders who participate do form a like minded  "group" of individuals so that cheap multiple, non friendly offers could be blocked. 
Comment by Donein25 on Jul 07, 2023 9:54am
Viking; this is the first I am hearing of you being present at the AGM. Can you share any more information. I would be curious if any mention made of how many patients would be needed for AA application? Other info?
Comment by Vikingstock on Jul 07, 2023 10:19am
If you have read Jaro77 review notes of the AGM meeting, they are very good and covered key areas. Don't have anything to add. 
Comment by skyhawk1 on Jul 07, 2023 10:09am
Yup ~ kinda!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250